Bulletin
Investor Alert

Amgen Inc.

NAS: AMGN

GO
/marketstate/country/us

After Hours

/zigman2/quotes/209157011/composite

$

267.46

Change

-0.24 -0.09%

Volume

Volume 199,353

Sep 22, 2023, 7:50 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209157011/composite

Previous close

$ 269.41

$ 267.70

Change

-1.71 -0.63%

Day low

Day high

$266.52

$269.50

Open
Open: 267.67

52 week low

52 week high

$211.71

$296.67

Open

Market cap

$143.19B

Average volume

2.54M

P/E ratio

18.05

Rev. per Employee

$1.05M

EPS

14.83

Dividend

2.13

Div yield

3.18%

Ex dividend date

8/17/23

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/amgn

MarketWatch News on AMGN

  1. Dow's nearly 100-point rally led by gains for shares of Amgen, IBM

    2:01 p.m. Sept. 20, 2023

    - MarketWatch Automation

  2. IBM, Amgen share gains contribute to Dow's nearly 200-point jump

    11:13 a.m. Sept. 20, 2023

    - MarketWatch Automation

  3. Dow's 320-point rally led by gains in shares of JPMorgan Chase, Amgen

    12:16 p.m. Sept. 14, 2023

    - MarketWatch Automation

  4. Dow's nearly 100-point drop led by losses for shares of Amgen, Procter & Gamble

    10:09 a.m. Sept. 12, 2023

    - MarketWatch Automation

  5. These four Dow stocks take top prizes for dividend growth

    8:13 a.m. Sept. 9, 2023

    - Philip van Doorn

  6. Amgen, FTC Settle Over $27.8 Billion Horizon Deal

    2:54 p.m. Sept. 1, 2023

    - Karishma Vanjani

  7. These Stocks Led the Market in August. It's Still Tech's Year.

    5:26 p.m. Aug. 31, 2023

    - Angela Palumbo

  8. First 10 Drugs Picked for Medicare Price Negotiations

    3:26 p.m. Aug. 29, 2023

    - Bill Alpert

  9. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/amgn

Other News on AMGN

  1. A New Way to Protect Against Heart Attacks

    2:32 p.m. Today

    - The Wall Street Journal Interactive Edition

  2. Big Pharma’s Battle With the Biden Administration Could Have Legs

    9:46 a.m. Sept. 13, 2023

    - The Wall Street Journal Interactive Edition

  3. Biden FTC’s Antitrust Bark Proves Worse Than Its Bite

    2:33 a.m. Sept. 7, 2023

    - The Wall Street Journal Interactive Edition

  4. Amgen’s Deal for Horizon Therapeutics Clears Key Hurdle

    2:32 a.m. Sept. 2, 2023

    - The Wall Street Journal Interactive Edition

  5. Drug Price Controls Mean Slower Cures

    4:44 p.m. Aug. 30, 2023

    - The Wall Street Journal Interactive Edition

  6. Expensive Drugs Targeted for First U.S. Price Negotiations

    4:40 p.m. Aug. 31, 2023

    - The Wall Street Journal Interactive Edition

  7. FTC Pauses Challenge to Amgen’s $27.8 Billion Deal for Horizon Therapeutics

    6:03 p.m. Aug. 28, 2023

    - The Wall Street Journal Interactive Edition

  8. Biotech M&A Rebound Bodes Well for Venture Investors

    2:33 a.m. Aug. 11, 2023

    - The Wall Street Journal Interactive Edition

  9. Apple, Amazon, Starbucks to Report in Packed Earnings Week

    1:43 p.m. Aug. 1, 2023

    - The Wall Street Journal Interactive Edition

  10. How AbbVie’s Humira Still Reigns, Despite New Competition

    9:55 a.m. Aug. 1, 2023

    - The Wall Street Journal Interactive Edition

  11. A Soap Maker Cracks the Code to ‘Made in America’

    2:34 a.m. July 26, 2023

    - The Wall Street Journal Interactive Edition

  12. Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion

    4:15 p.m. July 14, 2023

    - The Wall Street Journal Interactive Edition

  13. Lina Khan Is Taking on the World’s Biggest Tech Companies—and Losing

    7:00 a.m. July 13, 2023

    - The Wall Street Journal Interactive Edition

  14. The Drugs That Are Gaining on Ozempic

    6:30 p.m. July 3, 2023

    - The Wall Street Journal Interactive Edition

  15. Even Mark Cuban Can’t Fix This Broken Drug System

    2:32 a.m. June 6, 2023

    - The Wall Street Journal Interactive Edition

  16. Elizabeth Warren and the FTC Are the Least of Amgen’s Problems

    2:32 a.m. May 25, 2023

    - The Wall Street Journal Interactive Edition

  17. Walmart, Tesla, Micron: Stocks That Defined the Week

    2:32 a.m. May 20, 2023

    - The Wall Street Journal Interactive Edition

  18. Antitrust Gone Wild Against Amgen

    9:42 a.m. May 19, 2023

    - The Wall Street Journal Interactive Edition

  19. Sanofi Wins Supreme Court Patent Dispute With Amgen

    2:33 a.m. May 19, 2023

    - The Wall Street Journal Interactive Edition

  20. FTC Moves to Block Amgen’s $27.8 Billion Deal for Horizon Therapeutics

    3:34 p.m. June 2, 2023

    - The Wall Street Journal Interactive Edition

  21. Loading more headlines...
/news/pressrelease/company/us/amgn

Press Releases on AMGN

  1. AMGEN Deadline Alert

    8:55 p.m. May 12, 2023

    - Newsfile Corp

  2. Amgen Deadline Alert

    7:46 p.m. May 11, 2023

    - Newsfile Corp

Rates »

Link to MarketWatch's Slice.